Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $1.9B bought by 478 insiders at 311 companies
- $8.7B sold by 573 insiders outside a trading plan
- $4.4B sold by 900 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
RSGRepublic Services, Inc.Cascade Investment, L.l.c.10% owner · +1 joint filer$289M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$158M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$138M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$74.4M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
-
GSATGlobalstar, Inc.James Monroe IIIDirector$29.8M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
INGMIngram Micro Holding CorporationPlatinum Equity, LLC10% owner · +9 joint filers$410M
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
NVDANvidia Corporation ComMark A StevensDirector$300M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
CHYMChime Financial, Inc.DST Global Advisors Ltd10% owner · +9 joint filers$237M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
-
LFSTLifeStance Health Group, Inc.Tpg Gp A, LLC10% owner · +2 joint filers$226M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Alexandros Pappas Insider, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Kimberly J Brumbaugh Director, +2 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more
-
John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more
-
Kourosh Nasser Zamanizadeh Director, Bessie Ross Wills Director, Nicole Sherman CEO, Stacey Graham Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
George Kurian CEONTAPNetApp, Inc.Planned sale$7.7M 40,000 shares at $191.42 11% of stakeTraded Sep 14 Filed Sep 16
-
Charles Lacey Compton III CEOFSLYFastly, Inc.Planned sale$1.3M 50,392 shares at $24.93 5.6% of stakeTraded Sep 14 Filed Sep 16
-
William Joseph Brennan CEOCRDOCredo Technology Group Holding LtdPlanned sale$2.5M 16,672 shares at $151.88 1% of stakeTraded Sep 14 Filed Sep 16
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$4.7M 49,000 shares at $96.37 8.1% of stakeTraded Sep 15–16 Filed Sep 16
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.8M 9,500 shares at $501.59 2.8% of stakeTraded Sep 15 Filed Sep 16
-
Sassine Ghazi CEOSNPSSynopsys, Inc.Planned sale$5.5M 14,604 shares at $374.88 16% of stakeTraded Sep 15 Filed Sep 16
-
Richard P Wallace CEOKLACKLA CorporationPlanned sale$12.4M 72,019 shares at $171.88 9.2% of stakeTraded Sep 15 Filed Sep 16
-
Rene F Jones CEOMTBM&T Bank CorporationPlanned sale$4.6M 19,396 shares at $239.35 16% of stakeTraded Sep 14 Filed Sep 16
-
Niraj Shah CEOWWayfair Inc.Planned sale$7.1M 69,000 shares at $103.35 19% of stakeTraded Sep 14 Filed Sep 16
-
Gregory Stephen Smith CEOTERTeradyne, Inc.Planned sale$1.4M 4,000 shares at $337.83 3.6% of stakeTraded Sep 15 Filed Sep 16
-
Gustav Soderstrom CEOSPOTSpotify Technology S APlanned sale$11.4M 20,913 shares at $544.19 51% of stakeTraded Sep 14 Filed Sep 16
-
Matthew J Murphy CEOMRVLMarvell Technology, Inc.Planned sale$1.7M 7,500 shares at $223.39 1% of stakeTraded Sep 15 Filed Sep 15
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$4.4M 20,000 shares at $220.44 0.3% of stakeTraded Sep 11–14 Filed Sep 15
-
Fumihide Esaka CEOAMBQAmbiq Micro, Inc.Planned sale$4M 63,500 shares at $62.70 12% of stakeTraded Sep 11–15 Filed Sep 15
-
Antonio F Neri CEOHPEHewlett Packard Enterprise CompanyPlanned sale$15.1M 250,000 shares at $60.44 15% of stakeTraded Sep 11 Filed Sep 15
-
Ashraf Alkarmi CEODBXDropbox, Inc.Planned sale$1M 28,800 shares at $35.54 2.8% of stakeTraded Sep 11 Filed Sep 15
-
Robert A Frist Jr. CEOHSTMHealthStream, Inc.Sale$4.3M 144,068 shares at $29.50 3.6% of stakeTraded Sep 14 Filed Sep 15
-
James Grant Conroy CEOROSTRoss Stores, Inc.Sale$11.3M 49,205 shares at $229.48 27% of stakeTraded Sep 14 Filed Sep 15
-
Tomer Weingarten CEOSSentinelOne, Inc.Planned sale$2.3M 114,890 shares at $19.89 6.2% of stakeTraded Sep 11 Filed Sep 15
-
Robert I Blum CEOCYTKCytokinetics, IncorporatedPlanned sale$7.3M 105,426 shares at $69.62Traded Sep 14–15 Filed Sep 15
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.8M 9,500 shares at $504.12 2.8% of stakeTraded Sep 14 Filed Sep 15
-
Morris Goldfarb CEOGIIIG-III Apparel Group, LTD.Buy$1.1M 40,000 shares at $27.94 +0.9% to stakeTraded Sep 14 Filed Sep 15
-
Robert S Keane CEOCMPRCimpress PLCSale$2.4M 28,000 shares at $84.89Traded Sep 11 Filed Sep 15
-
Jeffrey S Lorberbaum CEOMHKMohawk Industries, Inc.Sale$8.7M 68,625 shares at $127.07 15% of stakeTraded Sep 11–14 Filed Sep 15
-
David P Meeker CEORYTMRhythm Pharmaceuticals, Inc.Planned sale$5.1M 50,000 shares at $102.67 17% of stakeTraded Sep 14 Filed Sep 14
-
John C.m. Farquhar CEOHTFLHeartflow, Inc.Planned sale$1.8M 38,900 shares at $46.78 11% of stakeTraded Sep 10–11 Filed Sep 14
-
Andrew Houston CEODBXDropbox, Inc.Planned sale$13.4M 383,800 shares at $35.02 100% of stakeTraded Sep 10 Filed Sep 14
-
Spenser Skates CEOAMPLAmplitude, Inc.Planned sale$2.3M 185,000 shares at $12.30 100% of stakeTraded Sep 10 Filed Sep 14
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$8.4M 86,000 shares at $98.13 13% of stakeTraded Sep 11–14 Filed Sep 14
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.8M 9,500 shares at $500.82 2.8% of stakeTraded Sep 11 Filed Sep 14
-
Michael L Baur CEOSCSCScanSource, Inc.Sale$4.4M 77,339 shares at $57.39 28% of stakeTraded Sep 10–11 Filed Sep 14
-
Charles H Giancarlo CEOPEverpure, Inc.Planned sale$6.7M 70,000 shares at $95.11 4.3% of stakeTraded Sep 10 Filed Sep 14
-
Lisa T Su CEOAMDAdvanced Micro Devices, Inc.Planned sale$48.1M 95,000 shares at $506.80Traded Sep 10 Filed Sep 14
-
Peng Jonathan Zhao CEOBZKanzhun LimitedSale$6.1M 743,600 shares at $8.23 21% of stakeTraded Sep 10–11 Filed Sep 14
-
Daniyel Erdberg CEOSPAISafe Pro Group Inc.Sale$4M 1,000,000 shares at $4.00 21% of stakeTraded Sep 9 Filed Sep 11
-
John E Kao CEOALHCAlignment Healthcare, Inc.Planned sale$2.2M 172,600 shares at $12.96 22% of stakeTraded Sep 10 Filed Sep 11
-
Helen Torley CEOHALOHalozyme Therapeutics, Inc.Planned sale$6.4M 60,000 shares at $107.28 7.2% of stakeTraded Sep 9–11 Filed Sep 11
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$4.2M 20,000 shares at $209.55 0.3% of stakeTraded Sep 9–10 Filed Sep 11
-
Daniel Antonio Perez CEOHNGEHinge Health, Inc.Planned sale$22.4M 250,000 shares at $89.45Traded Sep 10 Filed Sep 11
-
Stefan Larsson CEOPVHPVH Corp.Buy$1M 14,179 shares at $70.53 +4.2% to stakeTraded Sep 11 Filed Sep 11
-
Paul Peter Tak CEOCADLCandel Therapeutics, Inc.Planned sale$3.2M 280,245 shares at $11.28 71% of stakeTraded Sep 10–11 Filed Sep 11
-
Kenneth Hvid CEOTKTeekay Corporation Ltd.Sale$1.9M 132,884 shares at $14.28 56% of stakeTraded Sep 11 Filed Sep 11
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$2M 20,500 shares at $96.31 2.9% of stakeTraded Sep 10 Filed Sep 11
-
Terrence A Duffy CEOCMECME Group Inc.Sale$4.1M 15,000 shares at $274.44 27% of stakeTraded Sep 10 Filed Sep 11
-
William John Sibold CEOMDGLMadrigal Pharmaceuticals, Inc.Planned sale$2.8M 5,221 shares at $542.39 2.6% of stakeTraded Sep 11 Filed Sep 11
-
William D Mosley CEOSTXSeagate Technology Hldngs PlSale$2.5M 2,849 shares at $862.13 0.9% of stakeTraded Sep 10 Filed Sep 11
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.8M 9,500 shares at $502.35 2.8% of stakeTraded Sep 10 Filed Sep 11
-
Dinesh V Ph D Patel CEOPTGXProtagonist Therapeutics, Inc.Planned sale$18.2M 125,000 shares at $145.92 19% of stakeTraded Sep 8–10 Filed Sep 10
-
Patrick Miles CEOATECAlphatec Holdings, Inc.Buy$1M 115,000 shares at $8.81 +2% to stakeTraded Sep 10 Filed Sep 10
-
Richard Lee Van Kirk Jr. CEOPDEXPro-Dex, Inc.Planned sale$1.2M 19,235 shares at $60.58 19% of stakeTraded Sep 9 Filed Sep 10
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.